China and the global stem cell bioeconomy: an emerging political strategy?

TY - JOUR

T1 - China and the global stem cell bioeconomy

T2 - an emerging political strategy?

AU - Salter, Brian

AU - Cooper, Melinda

AU - Dickins, Amanda

PY - 2006/9

Y1 - 2006/9

N2 - There is a growing consensus, amongst policy analysts and scientists alike, that China is likely to play a key role in the scientific, clinical and commercial development of stem cell research. However, to date, there exist few detailed analyses of China's current investment in the field. After introducing the UK's recent political strategy on stem cell science, this article develops an in-depth discussion of the formal organization of China's research and development in the area, as well as its rapidly evolving commercial, regulatory and ethical environment. From here, we go on to assess the probability of China's emergence as a global player in the increasingly internationalized business of stem cell biomedicine.

AB - There is a growing consensus, amongst policy analysts and scientists alike, that China is likely to play a key role in the scientific, clinical and commercial development of stem cell research. However, to date, there exist few detailed analyses of China's current investment in the field. After introducing the UK's recent political strategy on stem cell science, this article develops an in-depth discussion of the formal organization of China's research and development in the area, as well as its rapidly evolving commercial, regulatory and ethical environment. From here, we go on to assess the probability of China's emergence as a global player in the increasingly internationalized business of stem cell biomedicine.

U2 - 10.2217/17460751.1.5.671

DO - 10.2217/17460751.1.5.671

M3 - Article

C2 - 17465734

VL - 1

SP - 671

EP - 683

JO - Regenerative Medicine

JF - Regenerative Medicine

IS - 5

ER -